VarinderKaurMDFACP

PubMed

• 21 citations
  Pre-diagnosis blood glucose and prognosis in women with breast cancer.
  Behjatolah Monzavi-Karbassi, Rhonda Gentry, Varinder Kaur, Eric R. Siegel, Fariba Jousheghany
  Cancer & Metabolism. 2016-04-06
• 44 citations
  Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years.
  Kaur, Swami A, Daisy Alapat, Abdallah Ao, Pooja Motwani
  Hematology. 2018-01-01
• 30 citations
  Systemic Therapy for Melanoma: ASCO Guideline Update.
  Rahul Seth, Sanjiv S Agarwala, Hans Messersmith, Krishna C Alluri, Paolo A Ascierto
  Journal of Clinical Oncology. 2023-10-20

Journal Articles

• Addressing Opioid-Associated Constipation Using Quality Oncology Practice Initiative Scores and Plan-Do-Study-Act Cycles  
  Varinder Kaur, MD, Sajjad Haider, MD, Appalanaidu Sasapu, MD, Paulette Mehta, MD, Konstantinos Arnaoutakis, MD, Issam Makhoul, MD, Journal of Oncology Practice, 10/31/2016
• PTHrP(12-48) localization is intracellular and it inhibits cell proliferation and osteoclastogenesis  
  Kaur V, Kamalakar A,Akel N, Leitzel K, Allan L, Suva LJ, Cancer Research 75(15 Supplement):1041-1041, 8/1/2015

Abstracts/Posters

• Tracking Circulating Tumor HPV DNA with Early Cessation of Radiotherapy in Oropharynx Cancer
  ZS Rentiya, J Garneau, V Kaur, PW Read, NS Kalman, KL Fedder, E Dowling, DC Shonka, C McLaughlin, International Journal of Radiation Oncology, Biology, Physics, Washington, D.C., 10/1/2024
• Trial in Progress: CTEP 10492, A Phase 1/1b Study of the AKT Inhibitor Ipatasertib with Chemoradiation for Locally Advanced Head and Neck Squamous Cell Carcinoma
  MD Mattes, H Willers, Y Lin, LA Gharzai, E Alesi, CE Lominska, S Kim, M Haigentz, V Kaur, S Arnold, T Synold, JS Gutkind, L Wirth, A Hanker, R Said, LL Siu, SK Jabbour, International Journal of Radiation Oncology* Biology* Physics, Washington, D.C., 10/1/2024
• 879P VERSATILE-002: Survival with first-line treatment with PDS0101 therapeutic vaccine and pembrolizumab in HPV16-positive recurrent/metastatic head and neck squamous...
  J Weiss, J Kaczmar, KJ Harrington, R Mehra, F Worden, R Zinner, A Giri, H Kang, S Najeeb, T Panella, A Sukari, C Grant, V Kaur, S Jones, D Schaaf, K Price, Annals of Oncology, 9/1/2024
• Real world treatment patterns and outcomes for patients with melanoma brain metastasis: A single center experience
  Amrita Ladwa, Omar Elghawy, Jacob Friedberg, Varinder Kaur, Neuro-Oncology Advances, SNO/ASCO Annual Conference Aug 8-10, 2024, Denver, CO, 8/2/2024
• CTEP 10492, a phase 1/1b study of the AKT inhibitor ipatasertib with chemoradiation for locally advanced head and neck squamous cell carcinoma.
  Malcolm David Mattes, Henning Willers, Yong Lin, Laila A Gharzai, Erin R Alesi, Christopher E Lominska, Sung Kim, Missak Haigentz, Varinder Kaur, Susanne M Arnold, Tim..., Journal of Clinical Oncology, 42;16_suppl:TPS6127-TPS6127, 6/1/2024
• Impact of immune-related adverse events (irAE) onset on disease response and survival in patients (pts) with head-neck cancer treated with immune check point inhibitor...
  Reema Patel, Omar Elghawy, Adam Barsouk, Varinder Kaur, Journal of Clinical Oncology, 42;16_suppl:6028, 6/1/2024
• SDPS-10 DISPARITIES IN THE RISK OF CNS METASTASIS AND CLINICAL OUTCOMES IN PATIENTS WITH HER2- MUTATION POSITIVE (HER2+) NON-BREAST VERSUS HER2+ BREAST CANCERS
  Elghawy O, Horton B, Shen S, Kaur V, Neurooncol Adv, doi: 10.1093/noajnl/vdad070.070. PMCID: PMC10402440., 8/4/2023
• Enrollment Trends Among Patients With Breast Central Nervous System Metastasis in Active Clinical Trials
  Elghawy O, Banfield W, Wang J, Horton B, Kaur V, Cancer Research, Cancer Res (2023) 83 (5_Supplement): P2-13-01., 3/1/2023
• 1269 Immunotherapy (IO) associated acute interstitial nephritis, and outcomes after re-challenge: a single center experience
  Puthumana J, Elghawy O, Horton B, Kaur V, Journal for ImmunoTherapy of Cancer, doi: 10.1136/jitc-2023-SITC2023.1269, 2023
• P2-13-01: Enrollment Trends Among Patients With Breast Central Nervous System Metastasis in Active Clinical Trials
  Elghawy O, Banfield W, Wang J, Horton B, Kaur V, Cancer Res, 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, Philadelphia (PA), 12/6/2022
• Phase I study of M6620 (VX-970, berzosertib) in combination with cisplatin and XRT in patients with locally advanced head and neck squamous cell carcinoma
  A. Bhatia, Z. Chen, J. Bruce, C.E. Steuer, D.P. Zandberg, J.W. Riess, D. Mitchell, T.H. Davis, M. Patel, V. Kaur, S. Arnold, T.K. Owinokoko, Annals of Oncology, Annals of Oncology (2022) 33 (suppl_7): S295-S322. 10.1016/annonc/annonc1056, 9/10/2022
• CLRM-11 Current State of Clinical Trials for patients with melanoma brain metastases
  Elghawy O, Banfield W, Horton B, Kaur V, Neurooncology Advances, SNO/ASCO Annual Conference, Toronto, Canada, 8/5/2022
• Current State of clinical trials for patients with melanoma brain metastasis
  Elghawy O, Banfield W, Horton B, Kaur V, Neuro-oncology Advances, Neurooncol Adv. 2022 Aug; 4(Suppl 1): i8. doi: 10.1093/noajnl/vdac078.031, 8/2022
• 656MO Phase I study of M6620 (VX-970, berzosertib) in combination with cisplatin and XRT in patients with locally advanced head and neck squamous cell carcinoma
  Bhatia A, Chen Z, Bruce J, Steuer CE, Zandberg DP, Riess JW, Mitchell D, Davis TH, Patel M, Kaur V, Arnold S, Owonikoko TK, Annals of Oncology 33, S842, ESMO 2022, 2022
• A trial to evaluate the safety, immunogenicity, and clinical activity of a helper peptide vaccine plus PD-1 blockade (Mel64, PATHVACS: PD-1 antibody and T-helper vacci...
  Craig Slingluff, Kimberly Chianese-Bullock, Ileana Mauldin, Walter Olson, Kelly Smith, Lynn Dengel, Kathleen Haden, Elizabeth Gaughan, Varinder Kaur, William Grosh, Journal for ImmunoTherapy of Cancer, Volume 9, Issue suppl 2, 11/1/2021
• Outcome disparities in rural versus urban patients with head and neck cancer: Leveling the playing field
  Varinder Kaur, Anthony Rooney, Desai Raj Piyush, Journal of Clinical Oncology, Journal of Clinical Oncology 39, no. 15_suppl, 5/28/2021
• A trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC
  Slingluff CR, Petroni GR, Chianese-Bullock KA, Wages NA, Walson CO, Smith KT, Dengel LT, Dickinson A, Reed C, Gaughan EM, Grosh WW, Kaur V, Varghegyi N, Smolkin ME, Ga..., SITC 2019, Nov 6-10, 2019; p365, National Harbor, Maryland, 11/8/2019
• P365 A trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund's adjuvant, cyclophosphamide, and polyICLC (MEL63)
  Slingluff CL, Petroni GR, Chianese-Bullock KA, Wages NA, Olson WC, Smith KT, Dengel LT, Dickinson A, Reed C, Gaughan EM, Grosh WW, Kaur V, Varhegyi N, Smolkin ME, Gale..., Society of Immunotherapy of Cancer Annual Meeting, 11/2019
• Outcomes, characteristics and molecular profile of myeloid sarcoma: single center experience over 13 years
  Varinder Kaur, Pooja Motwani, Laura F Hutchins, Daisy V Alapat, Yogesh Jethava, 2016 American Society of Clinical Oncology Annual Conference, at Chicago, USA, Chicago, USA, 5/20/2016
• Overall Outcomes of Bing-Neel Syndrome after Treatment - a Review of 40 Cases
  Varinder Kaur, Al-Ola Abdallah, Arjun Swami, Shebli Atrash, Daisy V. Alapat, Zhifu Xiang, Pooja Motwani, Fade Mahmoud, Issam Makhoul, Peter Dean Emanuel, Blood Dec 2015, 126 (23) 5019, Florida, USA, 12/3/2015
• Tackling the burden of opioid medication associated constipation using QOPI scores and PDSA cycles
  Varinder kaur, Haider Sajjad, Appalanaidu Sasapu, Konstantinos Arnaoutakis, Issam Makhoul, Paulette Mehta, Federal Practitioner/AVAHO, Washington D.C, 10/2/2015
• Pre-diabetes and breast cancer outcomes: Abrogating the confounding effects of anti-diabetic therapy
  Varinder Kaur, Mazin A Safar, Eric Seigel, Jousheghany Fariba, Thomas Kiebler-Emmons, Behjatolah Monzavi-Karbassi, 2015- American Society of Clinical Oncology Annual Meeting, at Chicago, USA, May 29-June2, Chicago, USA, 5/20/2015
• 1041: PTHrP(12-48) localization is intracellular and it inhibits cell proliferation and osteoclastogenesis
  Varinder Kaur, Archana Kamalakar, Nisreen S Akel, Kim Leitzel, Allan Lipton, Larry J Suva, American Association of Cancer Research Annual Conference, Philadelphia, PA, April 18-22, 2015, Philadelphia, PA, April 18-22, 2015, 4/4/2015
• Join now to see all